For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses. About one in every eight U.S. adults is currently taking a ...
A shaky economy, wider adoption of weight-loss medication, and changing tastes seem to conspire against some food makers. A strained economy, the growing number of people on weight-loss drugs and ...
Glucagon-like peptide 1 (GLP-1) receptor agonists are a class of Type 2 diabetes drugs that improves blood sugar and may also lead to weight loss. These drugs — including Ozempic, Wegovy and Zepbound ...
A strained economy, the growing number of people on weight-loss drugs and changes to government food-assistance programs are some of the looming challenges for food producers in the new year. Makers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results